Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Original Research
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,259 | Dovepress* | 3,838+ | 132 | 3,970 | |
| PubMed Central* | 421 | 193 | 614 | ||
| Totals | 4,259 | 325 | 4,584 | ||
| *Since 28 March 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar